3,881
edits
Changes
Jump to navigation
Jump to search
Line 6:
Line 6: − − <br /> Line 19:
Line 17: + + + + + + + + + + − + + + Line 29:
Line 39: − + + + Line 38:
Line 50: − + + + Line 47:
Line 61: − + + + Line 56:
Line 72: − + + + Line 65:
Line 83: − + + + Line 74:
Line 94: − + + + Line 83:
Line 105: − + + + Line 92:
Line 116: − + + + Line 101:
Line 127: − + + + Line 110:
Line 138: − + + + Line 119:
Line 149: − + + + Line 128:
Line 160: − + + + Line 137:
Line 171: − + + + Line 146:
Line 182: − + + + Line 155:
Line 193: − + + + Line 164:
Line 204: − + + + Line 173:
Line 215: − + + + Line 182:
Line 226: − + + + Line 191:
Line 237: − + + + Line 200:
Line 248: − + + + Line 209:
Line 259: − + + + Line 218:
Line 270: − + + + Line 227:
Line 281: − + + + Line 236:
Line 292: − + + + Line 245:
Line 303: − + + + Line 254:
Line 314: − + + + Line 263:
Line 325: − + + + Line 272:
Line 336: − + + + Line 281:
Line 347: − + + + Line 290:
Line 358: − + + + Line 299:
Line 369: − + + + Line 308:
Line 380: − + + + Line 317:
Line 391: − + + + Line 326:
Line 402: − + + + Line 335:
Line 413: − + + + Line 344:
Line 424: − + + + Line 353:
Line 435: − + + + Line 362:
Line 446: − + + + Line 371:
Line 457: − + + + Line 380:
Line 468: − + + + Line 389:
Line 479: − + + + Line 398:
Line 490: − + + + Line 407:
Line 501: − + + + Line 416:
Line 512: − + + + Line 425:
Line 523: − + + + Line 434:
Line 534: − + + + Line 443:
Line 545: − + + + Line 452:
Line 556: − + + + Line 461:
Line 567: − + + + Line 470:
Line 578: − + + + Line 479:
Line 589: − + + + Line 488:
Line 600: − + + + Line 497:
Line 611: − + + + Line 506:
Line 622: − + + + Line 515:
Line 633: − + + + Line 524:
Line 644: − + + + Line 533:
Line 655: − + + + Line 542:
Line 666: − + + + Line 551:
Line 677: − + + + Line 560:
Line 688: − + + + Line 569:
Line 699: − + + + Line 578:
Line 710: − + + + Line 587:
Line 721: − + + + Line 596:
Line 732: − + + + Line 605:
Line 743: − + + + Line 614:
Line 754: − + + + Line 623:
Line 765: − + + + Line 632:
Line 776: − + + + Line 641:
Line 787: − + + + Line 650:
Line 798: − + + + Line 659:
Line 809: − + + + Line 668:
Line 820: − + + + Line 677:
Line 831: − + + + Line 686:
Line 842: − + + + Line 695:
Line 853: − + + + Line 704:
Line 864: − + + + Line 713:
Line 875: − + + + Line 722:
Line 886: − + + + Line 731:
Line 897: − + + + Line 740:
Line 908: + + + + + + + + + + +
HAN5:Volunteer Assignments and Opportunities (view source)
Revision as of 14:04, 25 February 2024
, 14:04, 25 February 2024no edit summary
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
{| class="wikitable" style="margin:auto"
{| class="wikitable" style="margin:auto"
|+<big>WHO Classification of Head and Neck Tumours (5th Edition) Content</big>
|+<big>WHO Classification of Head and Neck Tumours (5th Edition) Content</big>
!'''Notes'''
!'''Notes'''
|-
|-
|[[GTS5:Hereditary_papillary_renal_carcinoma_(MET)|Hereditary papillary renal carcinoma (MET)]]
|Disease
|
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Multiple_endocrine_neoplasia_type_2_(RET)|Multiple endocrine neoplasia type 2 (RET)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Juvenile_polyposis_syndrome_(BMPR1A,_SMAD4)|Juvenile polyposis syndrome (BMPR1A, SMAD4)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Hereditary_neuroblastoma_(ALK,_PHOX2B)|Hereditary neuroblastoma (ALK, PHOX2B)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Encephalocraniocutaneous_lipomatosis_(FGFR1)|Encephalocraniocutaneous lipomatosis (FGFR1)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Glucagon_cell_hyperplasia_and_neoplasia_(GCGR)|Glucagon cell hyperplasia and neoplasia (GCGR)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:McCune-Albright_syndrome_(GNAS)|McCune-Albright syndrome (GNAS)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Sturge-Weber_syndrome_(GNAQ)|Sturge-Weber syndrome (GNAQ)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Neurofibromatosis_type_1_(NF1)|Neurofibromatosis type 1 (NF1)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:NF2-related_schwannomatosis_(NF2)|NF2-related schwannomatosis (NF2)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Costello_syndrome_(HRAS)|Costello syndrome (HRAS)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Noonan_syndrome_(Various_genes)|Noonan syndrome (Various genes)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Schimmelpenning-Feuerstein-Mims_(HRAS,_KRAS)|Schimmelpenning-Feuerstein-Mims (HRAS, KRAS)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Carney_complex_(PRKAR1A,_PDE8B,_PDE11A)|Carney complex (PRKAR1A, PDE8B, PDE11A)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:PROS_syndrome_(PIK3CA)|PROS syndrome (PIK3CA)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Familial_adenomatous_polyposis_(APC)|Familial adenomatous polyposis (APC)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Gastric_Adenocarcinoma_and_Proximal_Polyposis_of_Stomach_-_GAPPS_(APC_promoter)|Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:AXIN2-associated_polyposis_(AXIN2)|AXIN2-associated polyposis (AXIN2)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Serrated_polyposis_(RNF43)|Serrated polyposis (RNF43)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:WT1_related_tumour_predisposition_syndrome_(WT1)|WT1 related tumour predisposition syndrome (WT1)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:WAGR_syndrome_(WT1)|WAGR syndrome (WT1)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Multiple_endocrine_neoplasia_type_1_(MEN1)|Multiple endocrine neoplasia type 1 (MEN1)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Peutz-Jeghers_syndrome_(STK11)|Peutz-Jeghers syndrome (STK11)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Hereditary_gastric_and_breast_cancer_syndrome_(CDH1,_CTNNA1)|Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Hereditary_mixed_polyposis_syndrome_(GREM1)|Hereditary mixed polyposis syndrome (GREM1)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Naevoid_basal_cell_carcinoma_syndrome_-_Gorlin_syndrome_(PTCH1,_SUFU,_GPR161)|Naevoid basal cell carcinoma syndrome - Gorlin syndrome (PTCH1, SUFU, GPR161)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:SMO-related_Curry-Jones_syndrome_(SMO)|SMO-related Curry-Jones syndrome (SMO)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:ELP1-related_medulloblastoma_predisposition_syndrome(ELP1)|ELP1-related medulloblastoma predisposition syndrome(ELP1)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Osteochondromatosis_(EXT1,_EXT2)|Osteochondromatosis (EXT1, EXT2)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Brooke-Spiegler_syndrome_(CYLD)|Brooke-Spiegler syndrome (CYLD)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Tuberous_sclerosis_(TSC1,_TSC1)|Tuberous sclerosis (TSC1, TSC1)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:PTEN_hamartoma_tumour_syndrome_(PTEN)|PTEN hamartoma tumour syndrome (PTEN)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Activated_Phosphatidylinositol-3-OH_kinase_δ_Syndrome_-_APDS_(PIK3CD)|Activated Phosphatidylinositol-3-OH kinase δ Syndrome - APDS (PIK3CD)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Multiple_endocrine_neoplasia_type_5,_MAX_related_tumours_(MAX)|Multiple endocrine neoplasia type 5, MAX related tumours (MAX)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:MAFA-related_familial_insulinomatosis_(MAFA)|MAFA-related familial insulinomatosis (MAFA)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Birt-Hogg-Dube_syndrome_(FLCN)|Birt-Hogg-Dube syndrome (FLCN)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Familial_chordoma_(TBXT)|Familial chordoma (TBXT)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Hyperparathyroidism_jaw_tumour_syndrome_(CDC73)|Hyperparathyroidism jaw tumour syndrome (CDC73)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Von_Hippel-Lindau_syndrome_(VHL)|Von Hippel-Lindau syndrome (VHL)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:SDH-deficient_tumour_syndrome_-_Hereditary_phaeochromocytoma-paraganglioma_syndromes_(SDHA,_SDHB,_SDHC,_SDHD,_SDHAF2)|SDH-deficient tumour syndrome - Hereditary phaeochromocytoma-paraganglioma syndromes (SDHA, SDHB, SDHC, SDHD, SDHAF2)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma_syndrome_(FH)|Hereditary leiomyomatosis and renal cell carcinoma syndrome (FH)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Hereditary_tyrosinaemia_type_1_(FAH)|Hereditary tyrosinaemia type 1 (FAH)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Li-Fraumeni_syndrome_(TP53)|Li-Fraumeni syndrome (TP53)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Retinoblastoma_syndrome_(RB1)|Retinoblastoma syndrome (RB1)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Multiple_endocrine_neoplasia_type_4_(CDKN1B)|Multiple endocrine neoplasia type 4 (CDKN1B)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:CDKN2A-related_tumour_predisposition_syndrome_(CDKN2A)|CDKN2A-related tumour predisposition syndrome (CDKN2A)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:CDK4-related_melanoma_predisposition_syndrome_(CDK4)|CDK4-related melanoma predisposition syndrome (CDK4)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Autoimmune_lymphoproliferative_syndrome_(FAS)|Autoimmune lymphoproliferative syndrome (FAS)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Lynch_Syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Lynch Syndrome (MLH1, PMS2, MSH2, MSH6)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Muir-Torre_syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Muir-Torre syndrome (MLH1, PMS2, MSH2, MSH6)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Constitutional_mismatch_repair_deficiency_(CMMRD)_syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:BRCA-related_cancer_predisposition_syndrome_(BRCA1,_BRCA2)|BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:PALB2-related_cancer_predisposition_syndrome_(PALB2)|PALB2-related cancer predisposition syndrome (PALB2)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:RAD51-related_cancer_predisposition_syndrome_(RAD51C,_RAD51D)|RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Fanconi_anaemia_(FANC_genes)|Fanconi anaemia (FANC genes)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:MUTYH-associated_polyposis_(MUTYH)|MUTYH-associated polyposis (MUTYH)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:NTHL1-related_tumour_syndrome_(NTHL1)|NTHL1-related tumour syndrome (NTHL1)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:MBD4-associated_neoplasia_syndrome_(MBD4)|MBD4-associated neoplasia syndrome (MBD4)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Xeroderma_Pigmentosum|Xeroderma Pigmentosum]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Ataxia-telangiectasia_syndrome_(ATM)|Ataxia-telangiectasia syndrome (ATM)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:CHEK2-related_hereditary_(breast)_cancer_predisposition_syndrome_(CHEK2)|CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Nijmegen_breakage_syndrome_(NBN)|Nijmegen breakage syndrome (NBN)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Polymerase_proofreading-associated_polyposis_(POLD1,_POLE)|Polymerase proofreading-associated polyposis (POLD1, POLE)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Bloom_syndrome_(BLM)|Bloom syndrome (BLM)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Werner_syndrome_(WRN)|Werner syndrome (WRN)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Rothmund-Thomson_syndrome_(ANAPC1,_RECQL4)|Rothmund-Thomson syndrome (ANAPC1, RECQL4)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:DDX41-related_haematologic_tumour_predisposition_syndrome_(DDX41)|DDX41-related haematologic tumour predisposition syndrome (DDX41)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Mosaic_variegated_aneuploidy_(BUB1B,_CEP57,_TRIP13,_BUB1,_BUB3)|Mosaic variegated aneuploidy (BUB1B, CEP57, TRIP13, BUB1, BUB3)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Klinefelter_syndrome|Klinefelter syndrome]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Turner_syndrome|Turner syndrome]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Down_syndrome|Down syndrome]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Dyskeratosis_congenita_(DKC1,_TERT,_TERC,_TINF2,_Other_IBMFS_genes)|Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:POT1_and_Shelterin-related_tumour_predisposition_syndrome_(POT1,_ACD,_TERF2IP,_TERT_promoter)|POT1 and Shelterin-related tumour predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Beckwith-Wiedemann_spectrum_(IGF2;_CDKN1C)|Beckwith-Wiedemann spectrum (IGF2; CDKN1C)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Enchondromatosis_(IDH1,_IDH2)|Enchondromatosis (IDH1, IDH2)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Rhabdoid_tumour_predisposition_syndrome_(SMARCB1,_SMARCA4)|Rhabdoid tumour predisposition syndrome (SMARCB1, SMARCA4)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Schwannomatosis_(SMARCB1,_LZTR1)|Schwannomatosis (SMARCB1, LZTR1)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Clear_cell_meningioma_predisposition_syndrome_(SMARCE1)|Clear cell meningioma predisposition syndrome (SMARCE1)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:Weaver_syndrome_(EZH2)|Weaver syndrome (EZH2)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:DICER1-related_tumour_predisposition_syndrome_(DICER1)|DICER1-related tumour predisposition syndrome (DICER1)]]
|Disease
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[GTS5:MicroRNA_processor_tumour_predisposition_syndromes_(DROSHA,_DGCR8)|MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)]]
|Disease
|
|
|
|
|
|
|
|-
|-
|[[GTS5:Goldenhar_syndrome_(MYT1,_SF3B2)|Goldenhar syndrome (MYT1, SF3B2)]]
|Disease
|
|
|
|
|
|
|
|
|
|-
|[[GTS5:BAP1-related_tumour_predisposition_syndrome_(BAP1)|BAP1-related tumour predisposition syndrome (BAP1)]]
|Disease
|Disease
|
|